Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Clinical trial NCT00793234 · COMPLETED

Trial details

NCT number: NCT00793234
Sponsor: ThromboGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Total Knee Replacement Surgery

Start date: 2008-12-01
Primary completion: 2010-01-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.